Key result
Inhaled particle-induced acute phase response drives cardiovascular risk and serves as a mechanistic assessment tool.
Answers are grounded in this paper and cite their sources.
Inhaled nanoparticles constitute a potential health hazard due to their size-dependent lung deposition and large surface to mass ratio. Exposure to high levels contributes to the risk of developing respiratory and cardiovascular diseases, as well as of lung cancer. Particle-induced acute phase response may be an important mechanism of action of particle-induced cardiovascular disease. Here, the authors review new important scientific evidence showing causal relationships between inhalation of particle and nanomaterials, induction of acute phase response, and risk of cardiovascular disease. Particle-induced acute phase response provides a means for risk assessment of particle-induced cardiovascular disease and underscores cardiovascular disease as an occupational disease.
No takes yet. Share an insight, caveat, or question.
Hadrup et al. (2020) conducted a review in Cardiovascular disease. Inhaled nanoparticles and nanomaterials was evaluated. Inhalation of particles and nanomaterials induces an acute phase response, which serves as an important mechanism and risk assessment tool for particle-induced cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: